| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Financial Officer
3 companies
Clague Laura is a Director at GNSS with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 16 sells.
Estimated insider holdings value: $2.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 2, 2021 | TVTX Travere Therapeutics, Inc. | Chief Financial Officer | Sell | 3,625 | $30.75 | $111,468.75 | -4.7% | |
| Nov 25, 2020 | TVTX Travere Therapeutics, Inc. | Chief Financial Officer | Sell | 7,500 | $23.29 | $174,675.00 | -14.9% | |
| Nov 16, 2020 | TVTX Travere Therapeutics, Inc. | Chief Financial Officer | Sell | 7,500 | $23.98 | $179,812.50 | -27.8% | |
| Nov 13, 2020 | TVTX Travere Therapeutics, Inc. | Chief Financial Officer | Sell | 7,500 | $23.61 | $177,071.25 | -21.8% | |
| Sep 23, 2020 | TVTX Travere Therapeutics, Inc. | Chief Financial Officer | Sell | 1,500 | $18.48 | $27,720.00 | -7.2% | |
| Sep 22, 2020 | TVTX Travere Therapeutics, Inc. | Chief Financial Officer | Sell | 1,500 | $18.59 | $27,885.00 | -6.7% | |
| May 12, 2020 | TVTX Travere Therapeutics, Inc. | Chief Financial Officer | Sell | 3,027 | $16.22 | $49,088.23 | -4.7% | |
| Mar 10, 2020 | TVTX Travere Therapeutics, Inc. | Chief Financial Officer | Sell | 4,000 | $15.02 | $60,080.00 | -15.1% | |
| May 16, 2019 | TVTX Travere Therapeutics, Inc. | Chief Financial Officer | Sell | 2,500 | $18.25 | $45,612.50 | -8.1% | |
| Feb 12, 2019 | TVTX Travere Therapeutics, Inc. | Chief Financial Officer | Sell | 2,033 | $21.44 | $43,587.46 | -8.8% |